Cargando…

Signal transduction in cancer /

One of the most exciting areas of cancer research now is the development of agents which can target signal transduction pathways that are activated inappropriately in malignant cells. The understanding of the molecular abnormalities which distinguish malignant cells from their normal counterparts ha...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Frank, David A., 1960-
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Boston : Kluwer Academic Publishers, ©2003.
Colección:Cancer treatment and research ; v. 115.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 a 4500
001 EBOOKCENTRAL_ocm54435758
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cnu---unuuu
008 040217s2003 maua ob 001 0 eng d
040 |a N$T  |b eng  |e pn  |c N$T  |d YDXCP  |d OCLCG  |d OCLCQ  |d TNF  |d MERUC  |d CCO  |d E7B  |d UV0  |d UAB  |d DKDLA  |d EBLCP  |d TXHLC  |d IDEBK  |d TULIB  |d OCLCO  |d OCLCQ  |d OCLCA  |d GW5XE  |d OCLCF  |d OCLCQ  |d NLGGC  |d OCLCQ  |d COO  |d VVL  |d OCLCQ  |d AZK  |d LOA  |d OCLCO  |d OCLCA  |d SUR  |d MOR  |d PIFBR  |d ZCU  |d OCLCO  |d OTZ  |d OCLCQ  |d COCUF  |d OCLCO  |d OCLCQ  |d OCLCO  |d WY@  |d OCLCO  |d OCLCA  |d U3W  |d OCLCO  |d OCLCA  |d LUE  |d OCLCO  |d STF  |d WRM  |d OCLCQ  |d CEF  |d NRAMU  |d ICG  |d VTS  |d OCLCQ  |d INT  |d VT2  |d TOF  |d AU@  |d OCLCQ  |d OCLCO  |d WYU  |d OCLCO  |d OCLCA  |d CANPU  |d DKC  |d OCLCQ  |d OCLCO  |d UX1  |d OCLCQ  |d OCLCO  |d OCLCA  |d W2U  |d CNTRU  |d M8D  |d OCLCA  |d UKCRE  |d AJS  |d UKAHL  |d INARC  |d SFB  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCL 
015 |a GBA311532  |2 bnb 
019 |a 55047679  |a 228110800  |a 228375376  |a 229222296  |a 473729586  |a 559451695  |a 646722592  |a 702111889  |a 779892996  |a 888771553  |a 961575219  |a 961624321  |a 962582909  |a 962649919  |a 966232026  |a 984863159  |a 988529447  |a 992071300  |a 992074299  |a 994731203  |a 1035657685  |a 1037927473  |a 1038592893  |a 1044579406  |a 1045503165  |a 1053069085  |a 1055335986  |a 1056325948  |a 1060827929  |a 1062983119  |a 1075479432  |a 1078840025  |a 1078848009  |a 1081294940  |a 1086880414  |a 1153563383  |a 1228559333  |a 1256501933 
020 |a 0306481588  |q (electronic bk.) 
020 |a 9780306481581  |q (electronic bk.) 
020 |a 6610461791 
020 |a 9786610461790 
020 |z 9781402073403 
020 |z 1402073402 
029 1 |a AU@  |b 000053247080 
029 1 |a AU@  |b 000066275890 
029 1 |a AU@  |b 000067500420 
029 1 |a DEBBG  |b BV044091113 
029 1 |a NZ1  |b 11773345 
029 1 |a NZ1  |b 12008075 
035 |a (OCoLC)54435758  |z (OCoLC)55047679  |z (OCoLC)228110800  |z (OCoLC)228375376  |z (OCoLC)229222296  |z (OCoLC)473729586  |z (OCoLC)559451695  |z (OCoLC)646722592  |z (OCoLC)702111889  |z (OCoLC)779892996  |z (OCoLC)888771553  |z (OCoLC)961575219  |z (OCoLC)961624321  |z (OCoLC)962582909  |z (OCoLC)962649919  |z (OCoLC)966232026  |z (OCoLC)984863159  |z (OCoLC)988529447  |z (OCoLC)992071300  |z (OCoLC)992074299  |z (OCoLC)994731203  |z (OCoLC)1035657685  |z (OCoLC)1037927473  |z (OCoLC)1038592893  |z (OCoLC)1044579406  |z (OCoLC)1045503165  |z (OCoLC)1053069085  |z (OCoLC)1055335986  |z (OCoLC)1056325948  |z (OCoLC)1060827929  |z (OCoLC)1062983119  |z (OCoLC)1075479432  |z (OCoLC)1078840025  |z (OCoLC)1078848009  |z (OCoLC)1081294940  |z (OCoLC)1086880414  |z (OCoLC)1153563383  |z (OCoLC)1228559333  |z (OCoLC)1256501933 
050 4 |a RC268.5  |b .S546 2003eb 
060 4 |a QZ 266  |b S578 2003 
072 7 |a MED  |x 062000  |2 bisacsh 
072 7 |a HEA  |x 039030  |2 bisacsh 
082 0 4 |a 616.99/4071  |2 22 
049 |a UAMI 
245 0 0 |a Signal transduction in cancer /  |c edited by David A. Frank. 
260 |a Boston :  |b Kluwer Academic Publishers,  |c ©2003. 
300 |a 1 online resource (354 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file 
490 1 |a CTAR ;  |v v. 115 
490 1 |a C.T.A.R. ;  |v v. 115 
504 |a Includes bibliographical references and index. 
588 0 |a Print version record. 
520 |a One of the most exciting areas of cancer research now is the development of agents which can target signal transduction pathways that are activated inappropriately in malignant cells. The understanding of the molecular abnormalities which distinguish malignant cells from their normal counterparts has grown tremendously. This volume summarizes the current research on the role that signal transduction pathways play in the pathogenesis of cancer and how this knowledge may be used to develop the next generation of more effective and less toxic anticancer agents. Series Editor comments: "The biologic behavior of both normal and cancer cells is determined by critical signal transduction pathways. This text provides a comprehensive review of the field. Leading investigators discuss key molecules that may prove to be important diagnostic and/or therapeutic targets." 
505 0 |a Receptors -- Growth, Survival and Migration: The Trk to Cancer -- The Role of Growth Factor Signaling in Malignancy -- TGF-? Signaling Alterations in Cancer -- Notch in Malignancy -- Intracellular Pathways -- cAMP Signaling in Cancer Genesis and Treatment -- PI3K/PTEN/Akt Pathway -- Wnt Signaling in Human Cancer -- Ras Signaling, Deregulation of Gene Expression and Oncogenesis -- Role of the RB Tumor Suppressor in Cancer -- Transcription Factors -- The Rel/NF-?B/I?B Signal Transduction Pathway and Cancer -- STAT Signaling in Cancer: Insights into Pathogenesis and Treatment Strategies -- Steroid Hormone Receptor Signaling in Cancer -- Cell Death Pathways -- Cell Death Signaling in Malignancy -- Ceramide and Sphingosine 1-Phosphate in Anti-Cancer Therapies. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Carcinogenesis. 
650 0 |a Cancer  |x Molecular aspects. 
650 0 |a Cellular signal transduction. 
650 1 2 |a Neoplasms  |x therapy 
650 2 |a Signal Transduction 
650 2 2 |a Neoplasms  |x physiopathology 
650 2 2 |a Signal Transduction  |x physiology 
650 2 |a Carcinogenesis 
650 6 |a Cancérogenèse. 
650 6 |a Cancer  |x Aspect moléculaire. 
650 6 |a Transduction du signal cellulaire. 
650 7 |a MEDICAL  |x Oncology.  |2 bisacsh 
650 7 |a HEALTH & FITNESS  |x Diseases  |x Cancer.  |2 bisacsh 
650 7 |a Cancer  |x Molecular aspects  |2 fast 
650 7 |a Carcinogenesis  |2 fast 
650 7 |a Cellular signal transduction  |2 fast 
700 1 |a Frank, David A.,  |d 1960-  |1 https://id.oclc.org/worldcat/entity/E39PCjDpDqR4PhQT9q8rPtQYvb 
758 |i has work:  |a Signal transduction in cancer (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCGvJCchmbprYXypq8DVMxC  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |t Signal transduction in cancer.  |d Boston : Kluwer Academic Publishers, ©2003  |z 1402073402  |w (DLC) 2002040606  |w (OCoLC)50803753 
830 0 |a Cancer treatment and research ;  |v v. 115. 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3035857  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH3773317 
938 |a EBL - Ebook Library  |b EBLB  |n EBL197798 
938 |a EBSCOhost  |b EBSC  |n 99465 
938 |a Internet Archive  |b INAR  |n signaltransducti0000unse_d4i4 
938 |a YBP Library Services  |b YANK  |n 2292574 
994 |a 92  |b IZTAP